[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Ammar Jassim Abed\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":49},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":4,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":5},"100619796","evaluation-of-sflt-1plgf-ratio-opg-and-seng-as-predictive-biomarkers-in-the-diagnosis-and-treatment-evaluation-of-preeclampsia-100619796",false,"NCT07349277","Evaluation of sFlt-1\u002FPlGF Ratio ,OPG and sEng as Predictive Biomarkers in the Diagnosis and Treatment Evaluation of Preeclampsia","Evaluation of sFlt-1\u002FPlGF Ratio, Osteoprotegerin (OPG) and Soluble Endoglin (sEng) as Predictive Biomarkers in the Diagnosis and Treatment Evaluation of Preeclampsia","PE-POSS","IInclusion Criteria:\n\n* Pregnant women between 20 and 36 weeks of gestation\n* Age between 18 and 45 years\n* Attending the antenatal clinic at the study site\n\nExclusion Criteria:\n\n* Chronic hypertension\n* Renal disease\n* Diabetes mellitus\n* Multiple gestations\n* Autoimmune disorders",true,"FEMALE","18 Years","45 Years",{"count":22,"type":23},120,"ESTIMATED","OBSERVATIONAL","his study investigates the effectiveness of three specific biological markers (biomarkers) in the blood-the sFlt-1\u002FPlGF ratio, soluble endoglin (sEng), and osteoprotegerin (OPG)-to better diagnose and monitor preeclampsia. Preeclampsia is a serious pregnancy complication characterized by high blood pressure and potential organ damage that affects 2-8% of pregnancies worldwide",[27,28,29],"Preeclampsia","Gestational Hypertension","Hypertensive Disorders of Pregnancy",[31,32,33,34,35,27,36],"sFlt-1\u002FPlGF ratio","Soluble Endoglin (sEng)","Osteoprotegerin (OPG)","Angiogenesis","Placental Dysfunction","methyldopa","RECRUITING","2026-01-15",{"date":40,"type":41},"2026-01-20","ACTUAL",{"date":43,"type":41},"2025-10-10",{"date":45,"type":23},"2026-04-30",{"name":47,"class":48},"Ammar Jassim Abed","OTHER",""]